Small Pharma Price Prediction

DMTTFDelisted Stock  USD 0.05  0.0009  1.80%   
As of 27th of November 2024, the value of RSI of Small Pharma's share price is approaching 49 suggesting that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Small Pharma, making its price go up or down.

Oversold Vs Overbought

49

 
Oversold
 
Overbought
Small Pharma stock price prediction is an act of determining the future value of Small Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Small Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Small Pharma and does not consider all of the tangible or intangible factors available from Small Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Small Pharma, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Small Pharma based on different types of headlines from major news networks to social media. Using Small Pharma hype-based prediction, you can estimate the value of Small Pharma from the perspective of Small Pharma response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Small Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Small Pharma to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Small because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Small Pharma after-hype prediction price

    
  USD 0.05  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Small Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.050.050.06
Details
Naive
Forecast
LowNextHigh
0.040.040.04
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.050.050.05
Details

Small Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Small Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Small Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Small Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Small Pharma Estimiated After-Hype Price Volatility

In the context of predicting Small Pharma's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Small Pharma's historical news coverage. Small Pharma's after-hype downside and upside margins for the prediction period are 0.05 and 0.06, respectively. We have considered Small Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.05
0.05
After-hype Price
0.06
Upside
Small Pharma is very steady at this time. Analysis and calculation of next after-hype price of Small Pharma is based on 3 months time horizon.

Small Pharma OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as Small Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Small Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Small Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.05
0.05
1.77 
0.00  
Notes

Small Pharma Hype Timeline

Small Pharma is currently traded for 0.05. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Small is anticipated to decline in value after the next headline, with the price expected to drop to 0.05. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -1.77%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on Small Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.05. About 31.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.15. Some equities with similar Price to Book (P/B) outperform the market in the long run. Small Pharma recorded a loss per share of 0.06. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be in a few days.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Small Pharma Related Hype Analysis

Having access to credible news sources related to Small Pharma's direct competition is more important than ever and may enhance your ability to predict Small Pharma's future price movements. Getting to know how Small Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Small Pharma may potentially react to the hype associated with one of its peers.

Small Pharma Additional Predictive Modules

Most predictive techniques to examine Small price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Small using various technical indicators. When you analyze Small charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Small Pharma Predictive Indicators

The successful prediction of Small Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Small Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Small Pharma based on analysis of Small Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Small Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Small Pharma's related companies.

Story Coverage note for Small Pharma

The number of cover stories for Small Pharma depends on current market conditions and Small Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Small Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Small Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Small Pharma Short Properties

Small Pharma's future price predictability will typically decrease when Small Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Small Pharma often depends not only on the future outlook of the potential Small Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Small Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding319.6 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Small OTC Stock

If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.